Johnson & Johnson vs Pharmadax
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Johnson & Johnson is the larger company by market value: $652.5 B against $98 M for Pharmadax, 6658 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 7, 2022 for Pharmadax). Pharmadax's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Johnson & Johnson JNJ · #23 in the world | Pharmadax 4191.TWO |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇹🇼 Taiwan |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1886 | — |
| Size | ||
| Market cap | $652.5 B | $98 M* |
| Revenue | $94.2 B | — |
| Net income | $26.8 B | — |
| Employees | 138,200 | — |
| Valuation | ||
| P/E ratio | 40.5× | — |
| Price to sales | 6.6× | — |
| Price to book | 8.0× | — |
| Free cash flow yield | 3.0% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026 | Market cap Jan 2022 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Johnson & Johnson or Pharmadax?
Johnson & Johnson is the larger company by market value: $652.5 B against $98 M for Pharmadax, 6658 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 7, 2022 for Pharmadax). Pharmadax's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
More about Johnson & Johnson
More about Pharmadax
Sources#
Every figure on this page comes from these, with the date shown next to it.